sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Healthcare IT / POC Diagnostics

POC Diagnostics Market By Product (hsTnI, BNP and NT-ProBNP, HbA1c, PCT, TSH & FT4, HIV POC, and Influenza POC) and By End User (Hospital, Home & Healthcare Centers, ACAD, Others): Europe and MEA Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

  • Publish On: Mar-2020
  • Total Pages: 190
  • Report Code: FAF-840
  • Base Year: 2019
  • Format:

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the POC diagnostics industry. The report analyzes and declares the historical and current trends analysis of the POC diagnostics industry and subsequently recommends the projected trends anticipated to be observed in the POC diagnostics market during the upcoming years.

The POC diagnostics market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire POC diagnostics market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the POC Diagnostics industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the POC Diagnostics industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the POC diagnostics market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the POC diagnostics industry. The POC diagnostics market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the POC dagnostics sector. Key strategic developments in the POC Diagnostics market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the POC Diagnostics market are appropriately highlighted in the report.

POC diagnostics are implemented at and nearby the place anywhere a patient originally encounters the health care system. Point of care diagnostics lets medical staff and physicians to exactly succeed actual, lab-quality diagnostic effects inside minutes slightly hours. Equally, healthcare starts to move to customers, the demand for checks that can be completed wherever the patient is placed.

Better-quality patient effects, the directly obtainability of test effects can be connected to the patient organization to simplify the effort of separate patients concluded the organization faster and let used for the treatment of additional patients in a reduced time frame.

The POC diagnostics market research report delivers an acute valuation and taxonomy of the POC diagnostics industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the POC diagnostics industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the POC diagnostics industry is provided for the leading economies of the world.

The POC diagnostics market is segmented based on product and end-user. On the basis of product segmentation, the market is classified into hsTnI, BNP and NT-ProBNP, HbA1c, PCT, TSH & FT4, HIV POC, and Influenza POC. In terms of end-user segmentation, the market is bifurcated into Hospital, Home & Healthcare Centers, ACAD, Others.

Some of the essential players operating in the POC Diagnostics market, but not restricted to include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, bioMérieux SA, Nova Biomedical, Becton Dickinson & Company, Siemens Healthcare GmbH, Trividia Health Inc., QIAGEN, Sekisui Diagnostics LLC, Quidel Corporation, and others.

The taxonomy of the POC diagnostics industry by its scope and segmentation is as follows:

Europe and MEA POC Diagnostics Market: By Product Segmentation Analysis (Customizable)

  • hsTnI
  • BNP and NT-ProBNP
  • HbA1c
  • PCT
  • TSH & FT4
  • HIV POC
  • Influenza POC

Europe and MEA POC Diagnostics Market: By End User Segmentation Analysis (Customizable)

  • Hospital
  • Home & Healthcare Centers
  • ACAD
  • Others

Europe and MEA POC Diagnostics Market: Regional Segmentation Analysis (Customizable)

  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. POC Diagnostics market – Product Analysis
    1. 2.1. Europe and MEA POC Diagnostics Market – Product Overview
    2. 2.2. Europe and MEA POC Diagnostics Market Share, by Product, 2019 & 2026 (USD Million)
    3. 2.3. hsTnI
      1. 2.3.1. Global hsTnI POC Diagnostics Market, 2016-2026 (USD Million)
    4. 2.4. BNP and NT-ProBNP
      1. 2.4.1. Global BNP and NT-ProBNP POC Diagnostics Market, 2016-2026 (USD Million)
    5. 2.5. HbA1c
      1. 2.5.1. Global HbA1c POC Diagnostics Market, 2016-2026 (USD Million)
    6. 2.6. PCT
      1. 2.6.1. Global PCT POC Diagnostics Market, 2016-2026 (USD Million)
    7. 2.7. TSH & FT4
      1. 2.7.1. Global TSH & FT4 POC Diagnostics Market, 2016-2026 (USD Million)
    8. 2.8. HIV POC
      1. 2.8.1. Global HIV POC POC Diagnostics Market, 2016-2026 (USD Million)
    9. 2.9. Influenza POC
      1. 2.9.1. Global Influenza POC POC Diagnostics Market, 2016-2026 (USD Million)
  3. CHAPTER 3. POC Diagnostics market – End-User Analysis
    1. 3.1. Europe and MEA POC Diagnostics Market – End-User Overview
    2. 3.2. Europe and MEA POC Diagnostics Market Share, by End-User, 2019 & 2026 (USD Million)
    3. 3.3. Hospital
      1. 3.3.1. Global Hospital POC Diagnostics Market, 2016-2026 (USD Million)
    4. 3.4. Home & Healthcare Centers
      1. 3.4.1. Global Home & Healthcare Centers POC Diagnostics Market, 2016-2026 (USD Million)
    5. 3.5. ACAD
      1. 3.5.1. Global ACAD POC Diagnostics Market, 2016-2026 (USD Million)
    6. 3.6. Others
      1. 3.6.1. Global Others POC Diagnostics Market, 2016-2026 (USD Million)
  4. CHAPTER 4. POC Diagnostics market – Regional Analysis
    1. 4.1. Europe and MEA POC Diagnostics Market Regional Overview
    2. 4.2. Europe and MEA POC Diagnostics Market Share, by Region, 2019 & 2026 (Value)
    3. 4.3. Europe
      1. 4.3.1. Europe POC Diagnostics Market size and forecast, 2016-2026
      2. 4.3.2. Europe POC Diagnostics Market, by Country, 2019 & 2026 (USD Million)
      3. 4.3.3. Europe POC Diagnostics Market, by Product, 2016-2026
        1. 4.3.3.1. Europe POC Diagnostics Market, by Product, 2016-2026 (USD Million)
      4. 4.3.4. Europe POC Diagnostics Market, by End-User, 2016-2026
        1. 4.3.4.1. Europe POC Diagnostics Market, by End-User, 2016-2026 (USD Million)
      5. 4.3.5. Germany
        1. 4.3.5.1. Germany Market size and forecast, 2016-2026 (USD Million)
      6. 4.3.6. France
        1. 4.3.6.1. France Market size and forecast, 2016-2026 (USD Million)
      7. 4.3.7. U.K.
        1. 4.3.7.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      8. 4.3.8. Italy
        1. 4.3.8.1. Italy Market size and forecast, 2016-2026 (USD Million)
      9. 4.3.9. Spain
        1. 4.3.9.1. Spain Market size and forecast, 2016-2026 (USD Million)
      10. 4.3.10. Rest of Europe
        1. 4.3.10.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    4. 4.4. The Middle-East and Africa
      1. 4.4.1. The Middle-East and Africa POC Diagnostics Market size and forecast, 2016-2026
      2. 4.4.2. The Middle-East and Africa POC Diagnostics Market, by Country, 2019 & 2026 (USD Million)
      3. 4.4.3. The Middle-East and Africa POC Diagnostics Market, by Product, 2016-2026
        1. 4.4.3.1. The Middle-East and Africa POC Diagnostics Market, by Product, 2016-2026 (USD Million)
      4. 4.4.4. The Middle-East and Africa POC Diagnostics Market, by End-User, 2016-2026
        1. 4.4.4.1. The Middle-East and Africa POC Diagnostics Market, by End-User, 2016-2026 (USD Million)
      5. 4.4.5. GCC Countries
        1. 4.4.5.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      6. 4.4.6. South Africa
        1. 4.4.6.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      7. 4.4.7. Rest of Middle-East Africa
        1. 4.4.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  5. CHAPTER 5. POC Diagnostics market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. F. Hoffmann-La Roche Ltd.
      1. 6.1.1. Company Overview
      2. 6.1.2. F. Hoffmann-La Roche Ltd. Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Danaher Corporation
      1. 6.2.1. Company Overview
      2. 6.2.2. Danaher Corporation Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. Abbott Laboratories
      1. 6.3.1. Company Overview
      2. 6.3.2. Abbott Laboratories Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. bioMérieux SA
      1. 6.4.1. Company Overview
      2. 6.4.2. bioMérieux SA Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Nova Biomedical
      1. 6.5.1. Company Overview
      2. 6.5.2. Nova Biomedical Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Becton Dickinson & Company
      1. 6.6.1. Company Overview
      2. 6.6.2. Becton Dickinson & Company Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. Siemens Healthcare GmbH
      1. 6.7.1. Company Overview
      2. 6.7.2. Siemens Healthcare GmbH Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. Trividia Health Inc.
      1. 6.8.1. Company Overview
      2. 6.8.2. Trividia Health Inc. Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. QIAGEN
      1. 6.9.1. Company Overview
      2. 6.9.2. QIAGEN Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. Sekisui Diagnostics LLC
      1. 6.10.1. Company Overview
      2. 6.10.2. Sekisui Diagnostics LLC Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
    11. 6.11. Quidel Corporation
      1. 6.11.1. Company Overview
      2. 6.11.2. Quidel Corporation Revenue and Gross Margin
      3. 6.11.3. Product portfolio
      4. 6.11.4. Recent initiatives
    12. 6.12. and others
      1. 6.12.1. Company Overview
      2. 6.12.2. and others Revenue and Gross Margin
      3. 6.12.3. Product portfolio
      4. 6.12.4. Recent initiatives
  7. CHAPTER 7. POC Diagnostics — Industry Analysis
    1. 7.1. POC Diagnostics Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. POC Diagnostics Market – Attractiveness Analysis
      1. 7.4.1. By Product
      2. 7.4.2. By End-User
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Europe and MEA POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 2 Europe and MEA POC Diagnostics Market Share, by Product, 2019 & 2026 (USD Million)
        FIG. 3 Europe and MEA hsTnI POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 4 Europe and MEA BNP and NT-ProBNP POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 5 Europe and MEA HbA1c POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 6 Europe and MEA PCT POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 7 Europe and MEA TSH & FT4 POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 8 Europe and MEA HIV POC POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 9 Europe and MEA Influenza POC POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 10 Europe and MEA POC Diagnostics Market Share, by End-User, 2019 & 2026 (USD Million)
        FIG. 11 Europe and MEA Hospital POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 12 Europe and MEA Home & Healthcare Centers POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 13 Europe and MEA ACAD POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 14 Europe and MEA Others POC Diagnostics Market, 2016-2026 (USD Million)
        FIG. 15 Europe and MEA POC Diagnostics Market Share, by Region, 2019 & 2026
        FIG. 16 Europe POC Diagnostics Market, 2016-2026
        FIG. 17 Germany POC Diagnostics Market, 2016-2026
        FIG. 18 France POC Diagnostics Market, 2016-2026
        FIG. 19 U.K. POC Diagnostics Market, 2016-2026
        FIG. 20 Italy POC Diagnostics Market, 2016-2026
        FIG. 21 Spain POC Diagnostics Market, 2016-2026
        FIG. 22 Rest of Europe POC Diagnostics Market, 2016-2026
        FIG. 23 The Middle-East and Africa POC Diagnostics Market, 2016-2026
        FIG. 24 GCC Countries POC Diagnostics Market, 2016-2026
        FIG. 25 South Africa POC Diagnostics Market, 2016-2026
        FIG. 26 Rest of Middle-East Africa POC Diagnostics Market, 2016-2026
        FIG. 27 Competitor Market Share – Revenue
        FIG. 28 F. Hoffmann-La Roche Ltd. Revenue and Growth Rate
        FIG. 29 F. Hoffmann-La Roche Ltd. Market Share
        FIG. 30 Danaher Corporation Revenue and Growth Rate
        FIG. 31 Danaher Corporation Market Share
        FIG. 32 Abbott Laboratories Revenue and Growth Rate
        FIG. 33 Abbott Laboratories Market Share
        FIG. 34 bioMérieux SA Revenue and Growth Rate
        FIG. 35 bioMérieux SA Market Share
        FIG. 36 Nova Biomedical Revenue and Growth Rate
        FIG. 37 Nova Biomedical Market Share
        FIG. 38 Becton Dickinson & Company Revenue and Growth Rate
        FIG. 39 Becton Dickinson & Company Market Share
        FIG. 40 Siemens Healthcare GmbH Revenue and Growth Rate
        FIG. 41 Siemens Healthcare GmbH Market Share
        FIG. 42 Trividia Health Inc. Revenue and Growth Rate
        FIG. 43 Trividia Health Inc. Market Share
        FIG. 44 QIAGEN Revenue and Growth Rate
        FIG. 45 QIAGEN Market Share
        FIG. 46 Sekisui Diagnostics LLC Revenue and Growth Rate
        FIG. 47 Sekisui Diagnostics LLC Market Share
        FIG. 48 Quidel Corporation Revenue and Growth Rate
        FIG. 49 Quidel Corporation Market Share
        FIG. 50 and others Revenue and Growth Rate
        FIG. 51 and others Market Share
        FIG. 52 Market Dynamics
        FIG. 53 Global POC Diagnostics – Value Chain Analysis
        FIG. 54 Technology Roadmap and Timeline
        FIG. 55 Market Attractiveness Analysis – By Product
        FIG. 56 Market Attractiveness Analysis – By End-User
        FIG. 57 Market Attractiveness Analysis – By Region
        FIG. 58 Market Channel
        FIG. 59 Marketing Channel Development Trend
        FIG. 60 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Europe and MEA POC Diagnostics Market, 2019 & 2026 (USD Million)
        TABLE 2 Europe and MEA POC Diagnostics market, by Product, 2016-2026 (USD Million)
        TABLE 3 Europe and MEA POC Diagnostics market, by End-User, 2016-2026 (USD Million)
        TABLE 4 Europe and MEA POC Diagnostics market, by Region, 2016-2026 (USD Million)
        TABLE 5 Europe POC Diagnostics Market, by Product, 2016-2026 (USD Million)
        TABLE 6 Europe POC Diagnostics Market, by End-User, 2016-2026 (USD Million)
        TABLE 7 The Middle-East and Africa POC Diagnostics Market, by Product, 2016-2026 (USD Million)
        TABLE 8 The Middle-East and Africa POC Diagnostics Market, by End-User, 2016-2026 (USD Million)
        TABLE 9 Europe and MEA POC Diagnostics Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 10 Europe and MEA POC Diagnostics Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 11 Acquisitions and Mergers
        TABLE 12 New Product/Service Launch
        TABLE 13 Research & Development Activities
        TABLE 14 Market Drivers
        TABLE 15 Market Restraints
        TABLE 16 Market Opportunities

Key Insights from Primary Research

  • As per our major research, the POC diagnostics market is set to grow annually at a rate of around 7%
  • It was established through main research that the POC diagnostics market was valued at around USD 740.0 Million in 2019
  • Based on product type segmentation, the “HIV POC” category accounting for around 24% share, in 2019
  • Based on end-user segmentation, the “Hospital” category held the leading share at more than 69%, in 2019
  • In terms of product type HIV contributed the major market shares in terms of revenue due to its increasing incidences in South Africa and wide acceptance coupled with awareness across the European & African region.

Key Recommendations from Analysts

  • As per our analysts, Europe market is estimated to grow at a CAGR of 4% during 2019-2026
  •  Europe region growth is mainly driven by countries like Germany, France, UK, and others
  • Germany market accounted for a major revenue share of USD 108% Million in 2019 and continues to lead the POC Diagnostics market.
  • This industry is a steadily rising industry, and the degree of increasing consumption will show a smooth growth curve.
  • POC diagnostics the major part of manufacturing cost is attributed to the monthly wages/salary of labor and raw material sourcing.

Industry Major Market Players

  •  F. Hoffmann-La Roche Ltd.
  •  Danaher Corporation
  •  Abbott Laboratories
  •  bioMérieux SA
  •  Nova Biomedical
  •  Becton Dickinson & Company
  •  Siemens Healthcare GmbH
  •  Trividia Health Inc.
  •  QIAGEN
  •  Sekisui Diagnostics LLC
  •  Quidel Corporation

Related Reports

Direct-To-Patient Digital Marketing Market By Type (Offline and Online) and By Application (Ambulatory Surgical Centers, Hospitals, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Direct-To-Patient Digital Marketing industry. The report analyzes and declares the historical and current trends analysis of the Direct-To-Patient Digital Marketing ind...Read More

Mar-2020 | Price : $ 3850.00 | Pages: 162 | Report Code: ZMR-853 | Report Format:

Robotic Rehabilitation and Assistive Technologies Market by Product (Surveillance & Security, Humanoid, Rehabilitation, and Socially Assistive), Portability (Fixed base and Mobile) and Application (Stroke, Orthopedics, Cognitive & Motor Skills, Sports and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specializedandexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the Robotic Rehabilitation and Assistive Technologies industry. The report analyzes and declares the historical and current trends analysis of the Robotic Rehabilitation and ...Read More

Mar-2020 | Price : $ 3850.00 | Pages: 184 | Report Code: ZMR-707 | Report Format:

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions